Recommendations for evaluating the safety of medicinal products containing nanoparticles

Recommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.

Bibliographic Details
Main Authors: R. N. Alyautdin, B. K. Romanov
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:Безопасность и риск фармакотерапии
Subjects:
Online Access:https://www.risksafety.ru/jour/article/view/25
_version_ 1797224628778696704
author R. N. Alyautdin
B. K. Romanov
author_facet R. N. Alyautdin
B. K. Romanov
author_sort R. N. Alyautdin
collection DOAJ
description Recommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.
first_indexed 2024-03-08T22:27:43Z
format Article
id doaj.art-c23eee9836a947178fa9b752d9df57c6
institution Directory Open Access Journal
issn 2312-7821
2619-1164
language Russian
last_indexed 2024-04-24T13:56:09Z
publishDate 2018-02-01
publisher Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Безопасность и риск фармакотерапии
spelling doaj.art-c23eee9836a947178fa9b752d9df57c62024-04-03T17:56:36ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642018-02-0104102225Recommendations for evaluating the safety of medicinal products containing nanoparticlesR. N. Alyautdin0B. K. Romanov1Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», Ministry of Health of the Russian FederationRecommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.https://www.risksafety.ru/jour/article/view/25нанотехнологиитоксичностьлекарственное средствоnanotechnologytoxicitydrug
spellingShingle R. N. Alyautdin
B. K. Romanov
Recommendations for evaluating the safety of medicinal products containing nanoparticles
Безопасность и риск фармакотерапии
нанотехнологии
токсичность
лекарственное средство
nanotechnology
toxicity
drug
title Recommendations for evaluating the safety of medicinal products containing nanoparticles
title_full Recommendations for evaluating the safety of medicinal products containing nanoparticles
title_fullStr Recommendations for evaluating the safety of medicinal products containing nanoparticles
title_full_unstemmed Recommendations for evaluating the safety of medicinal products containing nanoparticles
title_short Recommendations for evaluating the safety of medicinal products containing nanoparticles
title_sort recommendations for evaluating the safety of medicinal products containing nanoparticles
topic нанотехнологии
токсичность
лекарственное средство
nanotechnology
toxicity
drug
url https://www.risksafety.ru/jour/article/view/25
work_keys_str_mv AT rnalyautdin recommendationsforevaluatingthesafetyofmedicinalproductscontainingnanoparticles
AT bkromanov recommendationsforevaluatingthesafetyofmedicinalproductscontainingnanoparticles